MEwens
J&J Settles With Texas: Johnson & Johnson said it would pay $158 million to settle claims by Texas that the company promoted its antipsychotic drug Risperdal for unapproved uses, resulting in overcharges to the state’s Medicaid program, the WSJ reports. J&J said the settlement, to be paid to a plaintiff who filed a […]
Continued Read ...
MEwens
ADHD Diagnosis: New American Academy of Pediatrics treatment guidelines for attention deficit hyperactivity disorder say ADHD can be diagnosed in kids as early as age four, and that Ritalin and similar drugs are an appropriate treatment even for those youngest kids with persistent symptoms when behavioral-management strategies don’t work, the WSJ reports. Many […]
Continued Read ...
MEwens
Raising Questions: The debate over whether antibiotics should be used less frequently in livestock has been revived by the recent recall of ground turkey tainted by salmonella bacteria that is resistant to many of the drugs, the WSJ reports. Food-safety experts say that routine use of antibiotics in feed as a preventive can […]
Continued Read ...
MEwens
New HIV Drug Option: The FDA approved Johnson & Johnson’s HIV drug rilpivirine, which will be marketed as Edurant and used in combination with other drugs in previously untreated patients infected by the virus, Dow Jones Newswires reports. The drug blocks replication of HIV.
Waiting Lists: Meantime, tight-budgeted states are trimming programs that assist […]
Continued Read ...
MEwens
Vaccines are perpetually victims of their own success, the author says.
Read more this great post here
Continued Read ...
MEwens
An editorial in BMJ accompanies a lengthy article by journalist Brian Deer that spells out the problems with the research, which was led by Andrew Wakefield.
Read more this great post here
Continued Read ...
MEwens
Wall Street Journal health blogger Katherine Hobson will take questions from readers in a live chat on Monday, Nov. 1 about the TEDMED conference in San Diego. Ask your questions now.
Read more this great post here
Continued Read ...
MEwens
Wall Street Journal health blogger Katherine Hobson will take questions from readers in a live chat on Monday, Nov. 1 about the TEDMED conference in San Diego. Ask your questions now.
Read more this great post here
Continued Read ...
MEwens
Even as vaccination rates were declining for kids in commercial plans, they were edging up — by less than 1% — for those covered by Medicaid.
Read more this great post here
Continued Read ...
Katherine Hobson
A family argues it should be able to sue Pfizer’s Wyeth unit over allegations that the drug maker could have, but didn’t, market a safer vaccine.
Read more this great post here
Continued Read ...
Next Page »
|
|
|